Related Experiment Video
Updated: May 20, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Artificial Intelligence to Promote Racial and Ethnic Cardiovascular Health Equity
Daniel Amponsah1, Ritu Thamman2, Eric Brandt3
1Division of Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA, USA.
Purpose Of Review:
The integration of artificial intelligence (AI) in medicine holds promise for transformative advancements aimed at improving healthcare outcomes. Amidst this promise, AI has been envisioned as a tool to detect and mitigate racial and ethnic inequity known to plague current cardiovascular care. However, this enthusiasm is dampened by the recognition that AI itself can harbor and propagate biases, necessitating a careful approach to ensure equity. This review highlights topics in the landscape of AI in cardiology, its role in identifying and addressing healthcare inequities, promoting diversity in research, concerns surrounding its applications, and proposed strategies for fostering equitable utilization.
Recent Findings:
Artificial intelligence has proven to be a valuable tool for clinicians in diagnosing and mitigating racial and ethnic inequities in cardiology, as well as the promotion of diversity in research. This promise is counterbalanced by the cautionary reality that AI can inadvertently perpetuate existent biases stemming from limited diversity in training data, inherent biases within datasets, and inadequate bias detection and monitoring mechanisms. Recognizing these concerns, experts emphasize the need for rigorous efforts to address these limitations in the development and deployment of AI within medicine.
Summary:
Implementing AI in cardiovascular care to identify and address racial and ethnic inequities requires careful design and execution, beginning with meticulous data collection and a thorough review of training datasets. Furthermore, ensuring equitable performance involves rigorous testing and continuous surveillance of algorithms. Lastly, the promotion of diversity in the AI workforce and engagement of stakeholders are crucial to the advancement of equity to ultimately realize the potential for artificial intelligence for cardiovascular health equity.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Stereotypes, Prejudice, and Discrimination
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Pre-Procedural Guidelines for Assessing Blood Pressure
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

